Yahoo Search Busca da Web

Resultado da Busca

  1. 16 de mai. de 2024 · The optimal approach to blood-pressure control in patients with acute stroke is uncertain. 1,2 Bundled-care protocols incorporating intensive treatment to lower blood pressure have been shown to...

  2. 19 de mai. de 2024 · Participants who were found to have undiagnosed COPD or asthma on spirometry were enrolled in a multicenter, randomized, controlled trial to determine whether early diagnosis and treatment reduces...

  3. Há 2 dias · O agente antiparasitário, ivermectina, demonstrou potencial para ser "reaproveitado" para uso na COVID-19 em vários estudos observacionais e randomizados controlados realizados fora dos Estados Unidos.

  4. 14 de mai. de 2024 · Since 1980, the American College of Cardiology (ACC) and American Heart Association (AHA) have translated scientific evidence into clinical practice guidelines with recommendations to improve cardiovascular health.

  5. 15 de mai. de 2024 · Placebo–controlled evidence from ORBITA-2 found that percutaneous cutaneous intervention (PCI) in stable coronary artery disease with little or no antianginal medication relieved angina, but residual symptoms persisted in many. The reason for this was unclear.

  6. 15 de mai. de 2024 · In patients with severe left ventricular dysfunction, neither complete anatomical nor viability-guided revascularization were associated with improved event-free survival compared to incomplete revascularization or treatment with medical therapy alone. Journal of the American College of Cardiology. Home.

  7. Há 2 dias · A Ivermectina, um medicamento de uso tanto veterinário como humano, tem sido bastante usada em casos de COVID-19. Sua utilização tem sido fundamentada em que, em experimentos laboratoriais (in-vitro, e não em seres vivos), se mostrou eficaz contra o virus causador da COVID-19.